In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm
Status: | Completed |
---|---|
Conditions: | Healthy Studies |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 4/21/2016 |
Start Date: | July 2011 |
End Date: | November 2011 |
The investigators propose to study oral commercial silver nanoparticle products on human
enzyme activity.
enzyme activity.
Inclusion Criteria:
- 18-80 years old without debilitating chronic disease or history of cardiovascular
event.
Exclusion Criteria:
- Women physically capable of becoming pregnant, who are not using 2 barrier methods of
birth control;
- Any female who is nursing;
- History of heavy metal allergy;
- History of asthma or Chronic Obstructive Pulmonary Disease;
- History of renal impairment;
- Symptoms of active upper respiratory disease at time of consent;
- Smoking more than 5 cigarettes or equivalent and not able to stop for 48 hours;
- Ability to discontinue chronic medications or nutraceuticals for 20 days or 5
half-lives of the agent, whichever is longer.
We found this trial at
1
site
University of Utah Research is a major component in the life of the U benefiting...
Click here to add this to my saved trials